Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

New Sopheon Software Release

7 Apr 2022 07:00

RNS Number : 5540H
Sopheon PLC
07 April 2022
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Sopheon Boosts Innovation System with Real-time Information and Collaboration Enhancements

Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, today announced a series of upgrades to its flagship product, Accolade®.

 

With an unprecedented level of transparency resulting in better analysis, a higher level of risk identification and improved reporting, Accolade enables stakeholders to make faster, fact-based decisions that drive innovation forward.

Accolade is a flexible and scalable single innovation system that provides the ability to control and manage innovation and new product development programs more effectively. Hundreds of long-standing blue-chip customers have experienced superior strategy-to-execution performance, increased time to market, streamlined operational costs and greater product success.

 

"Innovation projects face many speed bumps on the road from inception to the market. Sopheon has smoothed the road to innovation success with these latest communication and collaboration enhancements," said Michael Bauer, chief product officer of Sopheon. "Accolade provides a secure, self-service environment that allows stakeholders to be self-reliant in tracking processes and progress. By staying informed on a real-time basis, without needing the involvement of project managers, key stakeholders are empowered to make faster, fact-based decisions. Sopheon's Accolade provides the perfect mix of self-reliance, accountability, transparency and decision-making capabilities for ensuring new product success."

 

Benefits of the latest Accolade enhancements include:

 

Real-time information sharing - Accolade provides an easy and secure way for project and portfolio managers to set up and share information. Stakeholders can see live data automatically on-demand without needing a license for Accolade. This provides visibility into product portfolio performance and ensures that stakeholders are completely informed and aligned with relevant information that is always up to date.

 

Deeper collaboration - The addition of Slack to Sopheon's support for Microsoft Teams extends Accolade's communication and collaboration capabilities. The improved and fully integrated experience enables users to easily engage team members where they are most comfortable working in Accolade.

 

Valuable new insights - Sopheon's Trended Metrics is a powerful evaluation tool that helps users determine whether their product or portfolio is on track. Accolade automatically highlights and shows how specific metrics are trending and gives users an immediate indication where problems are likely to occur. It also captures updates since previous communications with stakeholders.

 

For further information contact:

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)

Alice Lane (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

Sopheon and Accolade are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAELKEDSAEAA
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.